| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.216 | 26.632 | 29.613 | 34.288 | 32.834 | 32.802 | 30.455 | 34.245 | 33.601 | 36.523 |
| Total Income - EUR | 24.216 | 26.632 | 29.613 | 34.288 | 32.834 | 32.802 | 30.455 | 34.273 | 33.601 | 36.523 |
| Total Expenses - EUR | 23.364 | 25.514 | 29.215 | 32.865 | 31.592 | 32.015 | 26.677 | 29.712 | 31.059 | 35.137 |
| Gross Profit/Loss - EUR | 853 | 1.118 | 398 | 1.423 | 1.242 | 786 | 3.778 | 4.560 | 2.541 | 1.387 |
| Net Profit/Loss - EUR | 195 | 585 | 102 | 1.080 | 914 | 580 | 3.552 | 3.950 | 2.143 | 1.169 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biomarget Com S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.689 | 2.681 | 3.640 | 4.741 | 5.991 | 4.859 | 3.967 | 4.346 | 6.490 | 7.756 |
| Inventories | 1.837 | 1.500 | 1.691 | 1.464 | 1.857 | 1.676 | 2.512 | 2.073 | 2.108 | 1.774 |
| Receivables | 0 | 35 | 96 | 658 | 645 | 634 | 619 | 621 | 619 | 650 |
| Cash | 1.852 | 1.147 | 1.854 | 2.620 | 3.489 | 2.549 | 837 | 1.652 | 3.763 | 5.332 |
| Shareholders Funds | 1.568 | 1.859 | 1.930 | 2.975 | 3.830 | 4.338 | 3.600 | 4.129 | 6.260 | 7.394 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.121 | 822 | 2.028 | 1.767 | 2.161 | 521 | 367 | 217 | 230 | 362 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4781
|
|||||||||
Comments - Biomarget Com S.r.l.